The complex roles of efferocytosis in cancer development, metastasis, and treatment

Epithelial-Mesenchymal Transitions in Development and Disease

Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · see citing works

Molecular mechanisms of epithelial–mesenchymal transition

Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091 · see citing works

Macrophage plasticity, polarization, and function in health and disease

Shapouri‐Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S., Mardani, F., Seifi, B., Mohammadi, A., Afshari, J. T., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26429 · Cited by 4,930 · see citing works

Complex networks orchestrate epithelial–mesenchymal transitions

Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,947 · see citing works

HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · see citing works

Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN

Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L. E., Worthen, G. S., & Albelda, S. Μ. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,382 · see citing works

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · see citing works

Role of reactive oxygen species (ROS) in apoptosis induction

Simon, H.-U., Haj-Yehia, A., & Levi-Schaffer, F. (2000) · Apoptosis · doi:10.1023/a:1009616228304 · Cited by 2,774 · see citing works

Hypoxia-inducible factors and the response to hypoxic stress

Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380 · see citing works

The tumor microenvironment and its role in promoting tumor growth

Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376 · see citing works

Necroptosis and its role in inflammation

Pasparakis, M., & Vandenabeele, P. (2015) · Nature · doi:10.1038/nature14191 · Cited by 2,148 · see citing works

Role of CD47 as a Marker of Self on Red Blood Cells

Oldenborg, P., Zheleznyak, A., Fang, Y., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,975 · see citing works

Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>

Nangalia, J., Massie, C. E., Baxter, E. J., Nice, F. L., Gundem, G., Wedge, D. C., Avezov, E., Li, J., Kollmann, K., Kent, D. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1312542 · Cited by 1,756 · see citing works

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512 · see citing works

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,418 · see citing works

Identification of a factor that links apoptotic cells to phagocytes

Hanayama, R., Tanaka, M., Miwa, K., Shinohara, A., Iwamatsu, A., & Nagata, S. (2002) · Nature · doi:10.1038/417182a · Cited by 1,401 · see citing works

Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice

Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377 · see citing works

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341 · see citing works

Immune regulatory function of B cells.

Mauri, C., & Bosma, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074934 · Cited by 1,278 · see citing works

Macrophage polarization in tumour progression

Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M., Biswas, S. K., Allavena, P., & Mantovani, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.004 · Cited by 1,241 · see citing works

Apoptotic cell clearance: basic biology and therapeutic potential

Poon, I. K. H., Lucas, C. D., Rossi, A. G., & Ravichandran, K. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3607 · Cited by 1,223 · see citing works

Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation

McDonald, B., Pittman, K., Menezes, G. B., Hirota, S. A., Slaba, I., Waterhouse, C. C. M., Beck, P. L., Muruve, D. A., & Kubes, P. (2010) · Science · doi:10.1126/science.1195491 · Cited by 1,210 · see citing works

History of myeloid-derived suppressor cells

Talmadge, J. E., & Gabrilovich, D. I. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3581 · Cited by 1,148 · see citing works

Epithelial-Mesenchymal Transition in Cancer: A Historical Overview

Ribatti, D., Tamma, R., & Annese, T. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100773 · Cited by 1,012 · see citing works

Macrophages in Tumor Microenvironments and the Progression of Tumors

Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/948098 · Cited by 1,003 · see citing works

Immunobiology of the TAM receptors

Lemke, G., & Rothlin, C. V. (2008) · Nature reviews. Immunology · doi:10.1038/nri2303 · Cited by 867 · see citing works

BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module

Park, D., Tosello‐Trampont, A., Elliott, M. R., Lu, M., Haney, L. B., Ma, Z., Klibanov, A. L., Mandell, J. W., & Ravichandran, K. S. (2007) · Nature · doi:10.1038/nature06329 · Cited by 848 · see citing works

Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

Chiba, S., Baghdadi, M., Akiba, H., Yoshiyama, H., Kinoshita, I., Dosaka-Akita, H., Fujioka, Y., Ohba, Y., Gorman, J. V., Colgan, J. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2376 · Cited by 838 · see citing works

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.497 · Cited by 800 · see citing works

Cadherin switching

Wheelock, M. J., Shintani, Y., Maeda, M., Fukumoto, Y., & Johnson, K. R. (2008) · Journal of Cell Science · doi:10.1242/jcs.000455 · Cited by 786 · see citing works

Role of reactive oxygen species in apoptosis: implications for cancer therapy

Matés, J. M., & Sánchez‐Jiménez, F. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00088-6 · Cited by 773 · see citing works

TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling, and Potential Therapeutic Targeting in Human Cancer

Linger, R. M. A., Keating, A. K., Earp, H. S., & Graham, D. K. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00002-x · Cited by 750 · see citing works

Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer

Birge, R. B., Boeltz, S., Kumar, S., Carlson, J., Wanderley, J. L. M., Calianese, D. C., Barcinski, M. A., Brekken, R. A., Huang, X., Hutchins, J., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.11 · Cited by 731 · see citing works

Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum

Michalak, M., Groenendyk, J., Szabo, E., Gold, L. I., & Opas, M. (2009) · Biochemical Journal · doi:10.1042/bj20081847 · Cited by 718 · see citing works

The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer

Graham, D. K., DeRyckere, D., Davies, K. D., & Earp, H. S. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3847 · Cited by 708 · see citing works

Induction of Immunological Tolerance by Apoptotic Cells Requires Caspase-Dependent Oxidation of High-Mobility Group Box-1 Protein

Kazama, H., Ricci, J.-E., Herndon, J. M., Hoppe, G., Green, D. R., & Ferguson, T. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.013 · Cited by 627 · see citing works

Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview

Wyllie, A. H. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf00048057 · Cited by 588 · see citing works

How Tolerogenic Dendritic Cells Induce Regulatory T Cells

Maldonado, R., & von Andrian, U. H. (2010) · Advances in immunology · doi:10.1016/b978-0-12-380995-7.00004-5 · Cited by 543 · see citing works

A Second Leukotriene B4 Receptor, Blt2

Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., & Shimizu, T. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.421 · Cited by 540 · see citing works

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells

Png, K. J., Halberg, N., Yoshida, M., & Tavazoie, S. F. (2011) · Nature · doi:10.1038/nature10661 · Cited by 531 · see citing works

Mitochondrial DNA copy number variation across human cancers

Reznik, E., Miller, M. L., Şenbabaoğlu, Y., Riaz, N., Sarungbam, J., Tickoo, S. K., Al‐Ahmadie, H. A., Lee, W., Seshan, V., Hakimi, A. A., et al. (2016) · eLife · doi:10.7554/elife.10769 · Cited by 515 · see citing works

Alarmins: awaiting a clinical response

Chan, J. K.-K., Roth, J., Oppenheim, J. J., Tracey, K. J., Vogl, T., Feldmann, M., Horwood, N. J., & Nanchahal, J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62423 · Cited by 507 · see citing works

HMGB1 in Cancer: Good, Bad, or Both?

Kang, R., Zhang, Q., Zeh, H. J., Lotze, M. T., & Tang, D. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0495 · Cited by 496 · see citing works

Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment

Myers, K. V., Amend, S. R., & Pienta, K. J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1022-2 · Cited by 482 · see citing works

Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein

Chen, Y., Zhang, S., Wang, Q., & Zhang, X. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0408-0 · Cited by 481 · see citing works

Hypoxic gene expression and metastasis

Le, Q., Denko, N. C., & Giaccia, A. J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031768.89246.d7 · Cited by 466 · see citing works

HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins

Bertheloot, D., & Latz, E. (2017) · Cellular &amp; Molecular Immunology · doi:10.1038/cmi.2016.34 · Cited by 455 · see citing works

A fate worse than death: apoptosis as an oncogenic process

Ichim, G., & Tait, S. W. G. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.58 · Cited by 451 · see citing works

Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response

Fucikova, J. P., Králíková, P., Fialová, A., Brtnický, T., Rob, L., Bartůňková, J., & Špíšek, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0950 · Cited by 393 · see citing works

HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression

Curtin, J. F., Liu, N., Candolfi, M., Xiong, W., Assi, H. H., Yagiz, K., Edwards, M. R., Michelsen, K. S., Kroeger, K. M., Liu, C., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000010 · Cited by 362 · see citing works

Mertk Receptor Mutation Reduces Efferocytosis Efficiency and Promotes Apoptotic Cell Accumulation and Plaque Necrosis in Atherosclerotic Lesions of <i>Apoe</i> ^−/− Mice

Thorp, E., Cui, D., Schrijvers, D. M., Kuriakose, G., & Tabas, I. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.167197 · Cited by 357 · see citing works

The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival

Kang, R., Tang, D., Schapiro, N. E., Livesey, K. M., Farkas, A. M., Loughran, P., Bierhaus, A., Lotze, M. T., & Zeh, H. J. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.149 · Cited by 333 · see citing works

Functional Cooperation between Snail1 and Twist in the Regulation of ZEB1 Expression during Epithelial to Mesenchymal Transition

Dave, N., Guaita‐Esteruelas, S., Gutarra, S., Frías, A., Beltran-Nebot, M., Peiró, S., & de Herreros, A. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.168625 · Cited by 332 · see citing works

Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis

Vyas, D., Laput, G. P., & Vyas, A. K. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s60114 · Cited by 309 · see citing works

Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis

Yurdagul, A., Doran, A. C., Cai, B., Fredman, G., & Tabas, I. A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00086 · Cited by 300 · see citing works

C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation

Bulla, R., Tripodo, C., Rami, D., Ling, G. S., Agostinis, C., Guarnotta, C., Zorzet, S., Durigutto, P., Botto, M., & Tedesco, F. (2016) · Nature Communications · doi:10.1038/ncomms10346 · Cited by 295 · see citing works

Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47−mediated ‘don’t-eat-me’ signal

Liu, M., O’Connor, R. S., Trefely, S., Graham, K. L., Snyder, N. W., & Beatty, G. L. (2019) · Nature Immunology · doi:10.1038/s41590-018-0292-y · Cited by 294 · see citing works

Discovery of N -(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily

Schroeder, G. M., An, Y., Cai, Z., Chen, X.-T., Clark, C. M., Cornelius, L. A. M., Dai, J., Gullo-Brown, J. L., Gupta, A. K., Henley, B., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801586s · Cited by 291 · see citing works

Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy

Ran, S., & Thorpe, P. E. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03928-7 · Cited by 280 · see citing works

Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘What does not kill me strengthens me’

Pisco, A. O., & Huang, S. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.146 · Cited by 278 · see citing works

Definition of the Lectin-like Properties of the Molecular Chaperone, Calreticulin, and Demonstration of Its Copurification with Endomannosidase from Rat Liver Golgi

Spiro, R. G., Zhu, Q., Bhoyroo, V. D., & Söling, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11588 · Cited by 277 · see citing works

Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments

Toivola, D. M., Tao, G., Habtezion, A., Liao, J., & Omary, M. B. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.09.004 · Cited by 273 · see citing works

Masking of Phosphatidylserine Inhibits Apoptotic Cell Engulfment and Induces Autoantibody Production in Mice

Asano, K., Miwa, M., Miwa, K., Hanayama, R., Nagase, H., Nagata, S., & Tanaka, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040342 · Cited by 268 · see citing works

Prognostic significance of tumor oxygenation in humans

Evans, S. M., & Koch, C. J. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00012-0 · Cited by 259 · see citing works

Macrophages eat cancer cells using their own calreticulin as a guide: Roles of TLR and Btk

Feng, M., Chen, J. Y., Weissman-Tsukamoto, R., Volkmer, J.-P., Ho, P. Y., McKenna, K. M., Cheshier, S. H., Zhang, M., Ring, N. G., Gip, P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424907112 · Cited by 253 · see citing works

Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner

Lima, L. G., Chammas, R. J., Monteiro, R. Q., Moreira, M. E. C., & Barcinski, M. A. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.03.041 · Cited by 252 · see citing works

Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death

Deng, H., Yang, W., Zhou, Z., Tian, R., Lin, L., Ma, Y., Song, J., & Chen, X. S. (2020) · Nature Communications · doi:10.1038/s41467-020-18745-6 · Cited by 243 · see citing works

CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease

Oldenborg, P. (2013) · ISRN Hematology · doi:10.1155/2013/614619 · Cited by 235 · see citing works

“Translating” Tumor Hypoxia: Unfolded Protein Response (UPR)–Dependent and UPR-Independent Pathways

Koumenis, C., & Wouters, B. G. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0150 · Cited by 228 · see citing works

Targeting Axl and Mer Kinases in Cancer

Verma, A. R., Warner, S. L., Vankayalapati, H., Bearss, D. J., & Sharma, S. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0116 · Cited by 226 · see citing works

Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma

Suzuki, Y., Mimura, K., Yoshimoto, Y., Watanabe, M., Ohkubo, Y., Izawa, S., Murata, K., Fujii, H., Nakano, T., & Kono, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0851 · Cited by 219 · see citing works

Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues

Gregory, C. D., & Pound, J. D. (2010) · The Journal of Pathology · doi:10.1002/path.2792 · Cited by 214 · see citing works

CD47: role in the immune system and application to cancer therapy

Hayat, S. M. G., Bianconi, V., Pirro, M., Jaafari, M. R., Hatamipour, M., & Sahebkar, A. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00469-5 · Cited by 204 · see citing works

TNF-α, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages

Alciato, F., Sainaghi, P. P., Sola, D., Castello, L. M., & Avanzi, G. C. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0909610 · Cited by 194 · see citing works

Interplay between inflammation and cancer

Piotrowski, I., Kulcenty, K. I., & Suchorska, W. M. (2020) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2020.04.004 · Cited by 190 · see citing works

MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis

Cook, R. S., Jacobsen, K. M., Wofford, A., DeRyckere, D., Stanford, J. C., Prieto, A. L., Redente, E. F., Sandahl, M. A., Hunter, D. M., Strunk, K. E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67655 · Cited by 186 · see citing works

Dying cell clearance and its impact on the outcome of tumor radiotherapy

Lauber, K., Ernst, A., Orth, M., i, M. H., & Belka, C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00116 · Cited by 186 · see citing works

Inhibition of Phosphatidylserine Recognition Heightens the Immunogenicity of Irradiated Lymphoma Cells In Vivo

Bondanza, A., Zimmermann, V. S., Rovere, P. Q., Turnay, J., Dumitriu, I. E., Stach, C. M., Voll, R. E., Gaipl, U. S., Bertling, W. M., Pöschl, E., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040327 · Cited by 176 · see citing works

Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate

Weigert, A., Johann, A. M., von Knethen, A., Schmidt, H., Geißlinger, G., & Brüne, B. (2006) · Blood · doi:10.1182/blood-2006-04-014852 · Cited by 173 · see citing works

Polarization of Prostate Cancer-associated Macrophages Is Induced by Milk Fat Globule-EGF Factor 8 (MFG-E8)-mediated Efferocytosis

Soki, F. N., Koh, A. J., Jones, J., Kim, Y. W., Dai, J., Keller, E. T., Pienta, K. J., Atabai, K., Roca, H., & McCauley, L. K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.571620 · Cited by 173 · see citing works

UNC2025 , a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor

Zhang, W., DeRyckere, D., Hunter, D. M., Liu, J., Stashko, M. A., Minson, K. A., Cummings, C. T., Lee, M., Glaros, T., Newton, D. L., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500749d · Cited by 172 · see citing works

Nanoscale Metal–Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy

Ni, K., Luo, T., Culbert, A. A., Kaufmann, M., Jiang, X., & Lin, W. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c05039 · Cited by 167 · see citing works

TLR9 ligation in pancreatic stellate cells promotes tumorigenesis

Zambirinis, C. P., Levie, E., Nguy, S., Avanzi, A., Barilla, R., Xu, Y., Seifert, L., Daley, D., Greco, S. H., Deutsch, M., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20142162 · Cited by 164 · see citing works

Review: milk fat globule-EGF factor 8 expression, function and plausible signal transduction in resolving inflammation

Aziz, M., Jacob, A., Matsuda, A., & Wang, P. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0630-0 · Cited by 163 · see citing works

Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution

Stanford, J. C., Young, C. D., Hicks, D. J., Owens, P., Williams, A., Vaught, D., Morrison, M. M., Lim, J., Williams, M. M., Brantley‐Sieders, D. M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76375 · Cited by 160 · see citing works

Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death

Asadzadeh, Z., Safarzadeh, E., Safaei, S., Baradaran, A., Mohammadi, A., Hajiasgharzadeh, K., Derakhshani, A., Argentiero, A., Silvestris, N., & Baradaran, B. (2020) · Cancers · doi:10.3390/cancers12041047 · Cited by 157 · see citing works

Efferocytosis in the tumor microenvironment

Werfel, T. A., & Cook, R. S. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0698-5 · Cited by 156 · see citing works

Cell rigidity and shape override CD47’s “self”-signaling in phagocytosis by hyperactivating myosin-II

Sosale, N. G., Rouhiparkouhi, T., Bradshaw, A. M., Dimova, R., Lipowsky, R., & Discher, D. E. (2014) · Blood · doi:10.1182/blood-2014-06-585299 · Cited by 154 · see citing works

The double-edged sword: Neurotoxicity of chemotherapy

Magge, R., & DeAngelis, L. M. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.09.012 · Cited by 154 · see citing works

Aspirin-triggered proresolving mediators stimulate resolution in cancer

Gilligan, M. M., Gartung, A., Sulciner, M. L., Norris, P. C., Sukhatme, V. P., Bielenberg, D. R., Huang, S., Kieran, M. W., Serhan, C. N., & Panigrahy, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804000116 · Cited by 152 · see citing works

Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis

Kirane, A., Ludwig, K. F., Sorrelle, N. B., Haaland, G. S., Sandal, T., Ranaweera, R., Toombs, J. E., Wang, M., Dineen, S. P., Micklem, D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2887-t · Cited by 150 · see citing works

Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation

Yin, Y., Huang, X., Lynn, K. D., & Thorpe, P. E. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0073 · Cited by 149 · see citing works

Wound healing‐like immune program facilitates postpartum mammary gland involution and tumor progression

Martinson, H. A., Jindal, S., Durand‐Rougely, C., Borges, V. F., & Schedin, P. S. (2014) · International Journal of Cancer · doi:10.1002/ijc.29181 · Cited by 145 · see citing works

Macrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention

Zhou, X., Liu, X., & Huang, L. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202006220 · Cited by 145 · see citing works

A therapeutic cancer vaccine against GL261 murine glioma

Kindy, M. S., Yu, J., Zhu, H., Smith, M. T., & Gattoni‐Celli, S. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-015-0757-9 · Cited by 144 · see citing works

Encyclopedia of Cell Biology

(2016) · Elsevier eBooks · doi:10.1016/c2011-1-06109-x · Cited by 143 · see citing works

Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone

Roca, H., Jones, J., Purica, M. C., Weidner, S., Koh, A. J., Kuo, R., Wilkinson, J. E., Wang, Y., Daignault‐Newton, S., Pienta, K. J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92466 · Cited by 141 · see citing works

Cutting Edge: Differential Effect of Apoptotic Versus Necrotic Tumor Cells on Macrophage Antitumor Activities

Reiter, I., Krammer, B. E., & Schwamberger, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.1730 · Cited by 140 · see citing works

Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP

Sun, L., Wang, Y., Wang, L., Yao, B., Chen, T., Li, Q., Liu, Z., Liu, R., Niu, Y., Song, T., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1163-6 · Cited by 136 · see citing works

Regulation of inflammation by members of the formyl-peptide receptor family

Chen, K., Bao, Z., Gong, W., Tang, P., Yoshimura, T., & Wang, J. M. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.06.012 · Cited by 135 · see citing works

Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms

Tajbakhsh, A., Rezaee, M., Kovanen, P. T., & Sahebkar, A. (2018) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2018.02.003 · Cited by 134 · see citing works

A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice

Huang, X., Bennett, M. A., & Thorpe, P. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0031 · Cited by 133 · see citing works

Antiphosphatidylserine Antibody Combined with Irradiation Damages Tumor Blood Vessels and Induces Tumor Immunity in a Rat Model of Glioblastoma

He, J., Yin, Y., Luster, T. A., Watkins, L. R., & Thorpe, P. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1499 · Cited by 130 · see citing works

Ultrasound induced cancer immunotherapy

Unga, J., & Hashida, M. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.004 · Cited by 123 · see citing works

The dual role and therapeutic potential of high-mobility group box 1 in cancer

He, S.-J., Cheng, J. Q., Xiao, F., Yu, Y., Tian, L., & Huang, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.17885 · Cited by 122 · see citing works

Mechanisms of Immune Signaling in Colitis-Associated Cancer

Waldner, M. J., & Neurath, M. F. (2014) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.006 · Cited by 120 · see citing works

HMGB1 released by irradiated tumor cells promotes living tumor cell proliferation via paracrine effect

He, S., Cheng, J. Q., Sun, L., Wang, Y., Wang, C., Liu, X., Zhang, Z., Zhao, M., Luo, Y., Tian, L., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0626-6 · Cited by 119 · see citing works

Calreticulin—Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients

Kiełbik, M., Szulc-Kiełbik, I., & Klink, M. (2021) · Cells · doi:10.3390/cells10010130 · Cited by 116 · see citing works

Genetic Studies of the Relationship of Tumour–Host Cells: Effect of Tumour Cells killed by X-rays upon the Growth of Admixed Viable Cells

Révész, L. (1956) · Nature · doi:10.1038/1781391a0 · Cited by 115 · see citing works

Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy

Leconet, W., Larbouret, C., Chardès, T., Thomas, G., Neiveyans, M., Busson, M., Jarlier, M., Radosevic‐Robin, N., Pugnière, M., Bernex, F., et al. (2013) · Oncogene · doi:10.1038/onc.2013.487 · Cited by 107 · see citing works

Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system

Ciampricotti, M., Hau, C., Doornebal, C. W., Jonkers, J., & de Visser, K. E. (2012) · Nature Medicine · doi:10.1038/nm.2652 · Cited by 104 · see citing works

High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy

Luo, Y., Chihara, Y., Fujimoto, K., Sasahira, T., Kuwada, M., Fujiwara, R., Fujii, K., Ohmori, H., & Kuniyasu, H. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.016 · Cited by 104 · see citing works

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy

Crittenden, M. R., Baird, J. R., Friedman, D. J., Savage, T., Uhde, L., Alice, A. F., Cottam, B., Young, K. H., Newell, P., Nguyen, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11823 · Cited by 103 · see citing works

Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes

Schcolnik‐Cabrera, A., Oldak, B., Juárez, M., Cruz-Rivera, M. Y., Flisser, A., & Mendlovic, F. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01532-0 · Cited by 103 · see citing works

Microenvironmental influences of apoptosis in vivo and in vitro

Gregory, C. D., & Pound, J. D. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0485-9 · Cited by 101 · see citing works

Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity

Nguyen, K.-Q. N., Tsou, W., Calarese, D. A., Kimani, S. G., Singh, S., Hsieh, S., Liu, Y., Lü, B., Wu, Y., Garforth, S., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.570838 · Cited by 99 · see citing works

MERTK as negative regulator of human T cell activation

Cabezón, R., Silva, E. A. C., Flórez‐Grau, G., Errasti, A. E., Calderón‐Gómez, E., Lozano, J. J., a, C. E., Ricart, E., Panés, J., Rothlin, C. V., et al. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0714-334r · Cited by 99 · see citing works

Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity

Davra, V., Kumar, S., Geng, K., Calianese, D. C., Mehta, D., Gadiyar, V., Kasikara, C., Lahey, K. C., Chang, Y., Wichroski, M. J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2066 · Cited by 96 · see citing works

Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1

Werfel, T. A., Elion, D. L., Rahman, B., Hicks, D. J., Sanchez, V. M., Ericsson, P. I. G., Nixon, M. J., James, J. L., Balko, J. M., Scherle, P., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1106 · Cited by 92 · see citing works

Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice

Stach, C. M., Turnay, J., Voll, R. E., Kern, P. M., Kolowos, W., Beyer, T. D., Kalden, J. R., & i, M. H. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400715 · Cited by 89 · see citing works

The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression

Ma, B., Cheng, H., Mu, C., Geng, G., Zhao, T., Luo, Q., Ma, K., Chang, R., Liu, Q., Gao, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08618-y · Cited by 89 · see citing works

Macrophages orchestrate the immune response to tumor cell death.

Gough, M. J., Melcher, A. A., Ahmed, A. U., Crittenden, M. R., Riddle, D. S., Linardakis, E., Ruchatz, A., Emiliusen, L., & Vile, R. G. (2001) · PubMed · Cited by 89 · see citing works

The role of dendritic cells in cancer

Hansen, M., & Andersen, M. H. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0592-y · Cited by 85 · see citing works

The Emerging Role of TYRO3 as a Therapeutic Target in Cancer

Smart, S. K., Vasileiadi, E., Wang, X., DeRyckere, D., & Graham, D. K. (2018) · Cancers · doi:10.3390/cancers10120474 · Cited by 85 · see citing works

The Role of Annexin A5 in the Modulation of the Immune Response Against Dying and Dead Cells

Munoz, L. E., Frey, B., Pausch, F., Baum, W., Müeller, R. B., Brachvogel, B., Pöschl, E., Rödel, F., von der Mark, K., i, M. H., et al. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707779941131 · Cited by 82 · see citing works

Prognostic stromal gene signatures in breast cancer

Winslow, S., Leandersson, K., Edsjö, A., & Larsson, C. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0530-2 · Cited by 81 · see citing works

TAM Receptor Inhibition–Implications for Cancer and the Immune System

Aehnlich, P., Powell, R., Peeters, M. J. W., Rahbech, A., & Straten, P. T. (2021) · Cancers · doi:10.3390/cancers13061195 · Cited by 81 · see citing works

Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation

Sandahl, M. A., Hunter, D. M., Strunk, K. E., Earp, H. S., & Cook, R. S. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-122 · Cited by 79 · see citing works

Combination of a monoclonal anti‐phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice

Beck, A. W., Luster, T. A., Miller, A. F., Holloway, S. E., Conner, C. R., Barnett, C. C., Thorpe, P. E., Fleming, J. B., & Brekken, R. A. (2005) · International Journal of Cancer · doi:10.1002/ijc.21684 · Cited by 74 · see citing works

The role of CD47-SIRPα immune checkpoint in tumor immune evasion and innate immunotherapy

Li, Z., Li, Y., Gao, J., Fu, Y., Hua, P., Jing, Y., Cai, M., Wang, H., & Tong, T. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119150 · Cited by 73 · see citing works

UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia In Vitro and In Vivo

Christoph, S., DeRyckere, D., Schlegel, J., Frazer, J. K., Batchelor, L. A., Trakhimets, A. Y., Sather, S., Hunter, D. M., Cummings, C. T., Liu, J., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0040 · Cited by 72 · see citing works

Kinetics and the Mechanism of Interaction of the Endoplasmic Reticulum Chaperone, Calreticulin, with Monoglucosylated (Glc1Man9GlcNAc2) Substrate

Patil, A. R., Thomas, C. J., & Surolia, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003102200 · Cited by 71 · see citing works

Leukotriene B4 receptors: Novel roles in immunological regulations

Yokomizo, T. (2010) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2010.08.002 · Cited by 71 · see citing works

Dendritic Cells Loaded with Ultrasound-Ablated Tumour Induce in vivo Specific Antitumour Immune Responses

Deng, J., Zhang, Y., Feng, J., & Wu, F. (2010) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2009.12.004 · Cited by 70 · see citing works

Curcumin: a potent agent to reverse epithelial-to-mesenchymal transition

Bahrami, A., Majeed, M. A., & Sahebkar, A. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00442-2 · Cited by 69 · see citing works

Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth

Agostinis, C., Vidergar, R., Belmonte, B., Mangogna, A., Amadio, L., Geri, P., Borelli, V., Zanconati, F., Tedesco, F., Confalonieri, M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01559 · Cited by 66 · see citing works

Functional Role of Milk Fat Globule-Epidermal Growth Factor VIII in Macrophage-Mediated Inflammatory Responses and Inflammatory/Autoimmune Diseases

Yi, Y. (2016) · Mediators of Inflammation · doi:10.1155/2016/5628486 · Cited by 63 · see citing works

An apoptosis-driven ‘onco-regenerative niche’: roles of tumour-associated macrophages and extracellular vesicles

Gregory, C., & Paterson, M. (2017) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2017.0003 · Cited by 60 · see citing works

Development of Bavituximab, a Vascular Targeting Agent with Immune-Modulating Properties, for Lung Cancer Treatment

DeRose, P. M., Thorpe, P. E., & Gerber, D. E. (2011) · Immunotherapy · doi:10.2217/imt.11.87 · Cited by 56 · see citing works

Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity

Kimani, S. G., Kumar, S., Bansal, N., Singh, K., Kholodovych, V. V., Comollo, T. W., Peng, Y., Kotenko, S. V., Sarafianos, S. G., Bertino, J. R., et al. (2017) · Scientific Reports · doi:10.1038/srep43908 · Cited by 56 · see citing works

Diminished airway macrophage expression of the Axl receptor tyrosine kinase is associated with defective efferocytosis in asthma

Grabiec, A. M., Denny, N., Doherty, J. A., Happonen, K. E., Hankinson, J., Connolly, E., Fife, M. E., Fujimori, T., Fujino, N., Goenka, A., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.03.024 · Cited by 56 · see citing works

Efferocytosis and Atherosclerosis: Regulation of Phagocyte Function by MicroRNAs.

Tajbakhsh, A., Bianconi, V., Pirro, M., Hayat, S. G. G., Johnston, T., & Sahebkar, A. (2019) · Trends in endocrinology and metabolism · doi:10.1016/j.tem.2019.07.006 · Cited by 55 · see citing works

Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy

Silva, I., Chammas, R. J., Lepique, A. P., & Jancar, S. (2017) · Oncogenesis · doi:10.1038/oncsis.2016.90 · Cited by 55 · see citing works

Discovery of Mer Specific Tyrosine Kinase Inhibitors for the Treatment and Prevention of Thrombosis

Zhang, W., McIver, A. L., Stashko, M. A., DeRyckere, D., Branchford, B. R., Hunter, D. M., Kireev, D., Miley, M. J., Norris-Drouin, J. L., Stewart, W. M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4013888 · Cited by 53 · see citing works

AnnexinA5 renders dead tumor cells immunogenic—implications for multimodal cancer therapies

Frey, B., Schildkopf, P., Rödel, F., Weiss, E., Munoz, L. E., i, M. H., Fietkau, R., & Gaipl, U. S. (2009) · Journal of Immunotoxicology · doi:10.3109/15476910903204058 · Cited by 53 · see citing works

Incorporation of palmitic acid or oleic acid into macrophage membrane lipids exerts differential effects on the function of normal mouse peritoneal macrophages

Lokesh, B. R., & Wrann, M. (1984) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(84)90215-7 · Cited by 51 · see citing works

Cisplatin Treatment Induces a Transient Increase in Tumorigenic Potential Associated with High Interleukin-6 Expression in Head and Neck Squamous Cell Carcinoma

Poth, K. J., Guminski, A. D., Thomas, G. P., Leo, P. J., Jabbar, I. A., & Saunders, N. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0258 · Cited by 51 · see citing works

TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis

Cartland, S. P., Genner, S. W., Martínez, G. J., Robertson, S. E. J., Kockx, M., Lin, R. C. Y., O’Sullivan, J., Koay, Y. C., Cholan, P. M., Kebede, M. A., et al. (2019) · iScience · doi:10.1016/j.isci.2018.12.037 · Cited by 51 · see citing works

Trabectedin Reduces Skeletal Prostate Cancer Tumor Size in Association with Effects on M2 Macrophages and Efferocytosis

Jones, J., Sinder, B. P., Paige, D. J., Soki, F. N., Koh, A. J., Thiele, S., Shiozawa, Y., Hofbauer, L. C., Daignault, S. D., Roca, H., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.11.003 · Cited by 50 · see citing works

Effect of soluble cleavage products of important receptors/ligands on efferocytosis: Their role in inflammatory, autoimmune and cardiovascular disease

Tajbakhsh, A., Hayat, S. M. G., Butler, A. E., & Sahebkar, A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.007 · Cited by 49 · see citing works

Changes in Tumor Growth and Metastatic Capacities of J82 Human Bladder Cancer Cells Suppressed by Down-Regulation of Calreticulin Expression

Lu, Y.-C., Chen, C., Wang, B., Hsu, W., Chen, S., Chang, K., Chang, C.-C., & Lee, H. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.015 · Cited by 46 · see citing works

New perspectives in cancer: Modulation of lipid metabolism and inflammation resolution

Prevete, N., Liotti, F., Amoresano, A., Pucci, P., de Paulis, A., & Melillo, R. M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.09.024 · Cited by 46 · see citing works

The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages

Ley, S., Weigert, A., Weichand, B., Henke, N., Mille-Baker, B., Janssen, R. A. J., & Brüne, B. (2012) · Oncogene · doi:10.1038/onc.2012.77 · Cited by 45 · see citing works

Macrophages programmed by apoptotic cells inhibit epithelial-mesenchymal transition in lung alveolar epithelial cells via PGE2, PGD2, and HGF

Yoon, Y.-S., Lee, Y.-J., Choi, Y., Park, Y. M., & Kang, J. L. (2016) · Scientific Reports · doi:10.1038/srep20992 · Cited by 45 · see citing works

Chemotherapy‐generated cell debris stimulates colon carcinoma tumor growth via osteopontin

Chang, J., Bhasin, S. S., Bielenberg, D. R., Sukhatme, V. P., Bhasin, M., Huang, S., Kieran, M. W., & Panigrahy, D. (2018) · The FASEB Journal · doi:10.1096/fj.201800019rr · Cited by 45 · see citing works

Nano-Infrared Imaging of Primary Neurons

Freitas, R. O., Cernescu, A., Engdahl, A., Paulus, A., Levandoski, J. E., Martinsson, I., Hebisch, E., Sandt, C., Gouras, G. K., Prinz, C. N., et al. (2021) · Cells · doi:10.3390/cells10102559 · Cited by 45 · see citing works

A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer

Chalasani, P., Marron, M., Roe, D. J., Clarke, K., Iannone, M., Livingston, R. B., Shan, J. S., & Stopeck, A. (2015) · Cancer Medicine · doi:10.1002/cam4.447 · Cited by 45 · see citing works

Programming of macrophages by UV-irradiated apoptotic cancer cells inhibits cancer progression and lung metastasis

Kim, Y.-B., Ahn, Y.-H., Jung, J.-H., Lee, Y.-J., Lee, J.-H., & Kang, J. L. (2019) · Cellular &amp; Molecular Immunology · doi:10.1038/s41423-019-0209-1 · Cited by 45 · see citing works

Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis

Avni, R., Cohen, B., & Neeman, M. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1632 · Cited by 44 · see citing works

Efferocytosis Creates a Tumor Microenvironment Supportive of Tumor Survival and Metastasis

(2015) · Cancer Cell &amp; Microenvironment · doi:10.14800/ccm.666 · Cited by 44 · see citing works

IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment

Munn, D. H., Sharma, M. D., Johnson, T. S., & Rodrı́guez, P. C. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2010-2 · Cited by 42 · see citing works

Tumor microenvironment, immune response and post-radiotherapy tumor clearance

Koukourakis, M. I., & Giatromanolaki, A. N. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02378-8 · Cited by 42 · see citing works

Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer

Digumarti, R., Bapsy, P. P., Suresh, A. V., Bhattacharyya, G. S., Dasappa, L., Shan, J. S., & Gerber, D. E. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.08.010 · Cited by 41 · see citing works

Evidence for induction of a tumor metastasis-receptive microenvironment for ovarian cancer cells in bone marrow and other organs as an unwanted and underestimated side effect of chemotherapy/radiotherapy

Gunjal, P., Schneider, G., Abdelbaset‐Ismail, A., Kakar, S. S., Kucia, M., & Ratajczak, M. Z. (2015) · Journal of Ovarian Research · doi:10.1186/s13048-015-0141-7 · Cited by 41 · see citing works

Kinetics of the tingible body macrophage response in mouse germinal center development and its depression with age

Smith, J. P., Lister, A. M., Tew, J. G., & Szakal, A. K. (1991) · The Anatomical Record · doi:10.1002/ar.1092290412 · Cited by 41 · see citing works

Microenvironmental Effects of Cell Death in Malignant Disease

Gregory, C. D., Ford, C. A., & Voss, J. J. L. P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-39406-0_3 · Cited by 41 · see citing works

Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer's disease: Pathological mechanisms and therapeutic outlooks

Tajbakhsh, A., Read, M. I., Barreto, G. E., Ávila-Rodriguez, M., Hayat, S. M. G., & Sahebkar, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173873 · Cited by 41 · see citing works

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting

Peeters, M. J. W., Rahbech, A., & Straten, P. T. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02421-w · Cited by 40 · see citing works

The immunological potential of apoptotic debris produced by tumor cells and during HIV infection

Kornbluth, R. S. (1994) · Immunology Letters · doi:10.1016/0165-2478(94)00149-9 · Cited by 38 · see citing works

Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling

Binnington, B., Nguyen, L., Kamani, M., Hossain, D., Marks, D. L., Budani, M., & Lingwood, C. A. (2015) · Glycobiology · doi:10.1093/glycob/cwv084 · Cited by 37 · see citing works

Surgery as a Double-Edged Sword: A Clinically Feasible Approach to Overcome the Metastasis-Promoting Effects of Surgery by Blunting Stress and Prostaglandin Responses

Benish, M., & Ben‐Eliyahu, S. (2010) · Cancers · doi:10.3390/cancers2041929 · Cited by 36 · see citing works

Regulation of efferocytosis by caspase-dependent apoptotic cell death in atherosclerosis

Tajbakhsh, A., Kovanen, P. T., Rezaee, M., Banach, M., Moallem, S. A., & Sahebkar, A. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105684 · Cited by 34 · see citing works

Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer.

Reers, S., Pfannerstill, A.-C., Rades, D., Maushagen, R., Andratschke, M., Pries, R., & Wollenberg, B. (2013) · PubMed · Cited by 33 · see citing works

JS‐K induces reactive oxygen species‐dependent anti‐cancer effects by targeting mitochondria respiratory chain complexes in gastric cancer

Zhao, X., Cai, A., Peng, Z., Liang, W., Xi, H., Li, P., Chen, G., Yu, J., & Chen, L. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14122 · Cited by 33 · see citing works

Long-Term Exposure to Inflammation Induces Differential Cytokine Patterns and Apoptosis in Dendritic Cells

Carstensen, L. S., Lie-Andersen, O., Obers, A., Crowther, M. D., Svane, I. M., & Hansen, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02702 · Cited by 32 · see citing works

The role of nuclear factors as “Find-Me”/alarmin signals and immunostimulation in defective efferocytosis and related disorders

Tajbakhsh, A., Rezaee, M., Barreto, G. E., Moallem, S. A., Henney, N. C., & Sahebkar, A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106134 · Cited by 30 · see citing works

MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer

Chen, C., & Liu, Y. (2021) · Pharmaceuticals · doi:10.3390/ph14020130 · Cited by 28 · see citing works

Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages

Kim, S. H., Saeidi, S., Zhong, X., Gwak, S.-Y., Muna, I. A., Park, S., Kim, S. H., Na, H., Joe, Y., Chung, H., et al. (2020) · Neoplasia · doi:10.1016/j.neo.2020.08.006 · Cited by 26 · see citing works

CD47 Functionalization of Nanoparticles as a Poly(ethylene glycol) Alternative: A Novel Approach to Improve Drug Delivery

Vandchali, N. R., Moadab, F., Taghizadeh, E., Tajbakhsh, A., & Hayat, S. M. G. (2021) · Current Drug Targets · doi:10.2174/1389450122666210204203514 · Cited by 26 · see citing works

‘Clustering’ SIRPα into the Plasma Membrane Lipid Microdomains Is Required for Activated Monocytes and Macrophages to Mediate Effective Cell Surface Interactions with CD47

Ha, B., Lv, Z., Bian, Z., Zhang, X., Mishra, A., & Liu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077615 · Cited by 25 · see citing works

Prognostic Implications of the Complement Protein C1Q and Its Correlation with Immune Infiltrates in Osteosarcoma

Huang, H., Tan, M., Li, Z., Yan, G., Li, K., Lu, D., Cui, X., He, S., Lei, D., Zhu, B., et al. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s295063 · Cited by 25 · see citing works

Role of CD47 and Signal Regulatory Protein Alpha (SIRPa) in Regulating the Clearance of Viable or Aged Blood Cells

Oldenborg, P. (2012) · Transfusion Medicine and Hemotherapy · doi:10.1159/000342537 · Cited by 24 · see citing works

PD-1/PD-L1 immune checkpoint blockade-based combinational treatment: Immunotherapeutic amplification strategies against colorectal cancer

Chen, Y., Liu, C., Zhu, S., Liang, X., Zhang, Q., Luo, X., Yuan, L., & Song, L. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107607 · Cited by 24 · see citing works

Ca2+ Flux: Searching for a Role in Efferocytosis of Apoptotic Cells in Atherosclerosis

Tajbakhsh, A., Kovanen, P. T., Rezaee, M., Banach, M., & Sahebkar, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122047 · Cited by 24 · see citing works

Cytokine-induced killer cells co-cultured with dendritic cells loaded with the protein lysate produced by radiofrequency ablation induce a specific antitumor response

Shan, C., Shi, L., Ding, M., Zhu, Y., Li, X., Xu, B., Jiang, J., & Wu, C. (2015) · Oncology Letters · doi:10.3892/ol.2015.2977 · Cited by 23 · see citing works

Reprograming of Tumor-Associated Macrophages in Breast Tumor-Bearing Mice under Chemotherapy by Targeting Heme Oxygenase-1

Kim, S. H., Kim, S., Park, J., Joe, Y., Lee, S. E., Saeidi, S., Zhong, X., Kim, S. H., Park, S., Na, H., et al. (2021) · Antioxidants · doi:10.3390/antiox10030470 · Cited by 22 · see citing works

Antibody‐mediated neutralization of autocrine Gas6 inhibits the growth of pancreatic ductal adenocarcinoma tumors in vivo

Moody, G. E., Belmontes, B., Masterman, S. K., Wang, W., King, C., Murawsky, C. M., Tsuruda, T. S., Liu, S., Radinsky, R., & Beltran, P. J. (2016) · International Journal of Cancer · doi:10.1002/ijc.30180 · Cited by 21 · see citing works

Hypoxia induces immunogenic cell death of cancer cells by enhancing the exposure of cell surface calreticulin in an endoplasmic reticulum stress‑dependent manner

Han, Y. K., Park, G., Bae, M., Kim, J., Jo, W. S., & Lee, C. (2019) · Oncology Letters · doi:10.3892/ol.2019.10986 · Cited by 18 · see citing works

BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy

Chen, Y., Lo, C., Chiu, T., Hsu, C., Yeh, T., Chen, C.-P., Huang, C., Huang, C.-Y., Wang, M., Huang, Y., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100897 · Cited by 17 · see citing works

Autoantigen-specific immune tolerance in pathological and physiological cell death: Nanotechnology comes into view

Tajbakhsh, A., Farahani, N., Gheibihayat, S. M., Mirkhabbaz, A. M., Savardashtaki, A., Hamblin, M. R., & Mirzaei, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107177 · Cited by 17 · see citing works

CXCL5/CXCL8 is a promising potential prognostic and tumor microenvironment-related cluster in hepatocellular carcinoma

Zhu, J. W., Zhou, Y., Wang, L., Hao, J., Chen, R., Liu, L., & Li, J. (2020) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-20-556 · Cited by 16 · see citing works

Differential action of polyunsaturated fatty acids and eicosanoids on bleomycin-induced cytotoxicity to neuroblastoma cells and lymphocytes

Polavarapu, S., Dwarakanath, B. S. R., & Das, U. N. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.72244 · Cited by 14 · see citing works

Potential Oncogenic Effect of the MERTK-Dependent Apoptotic-Cell Clearance Pathway in Starry-Sky B-Cell Lymphoma

Farnworth, S. L., Barth, N. D., Melville, L. A., Paterson, M., Lynch, C., Holland, P. J., Dransfield, I., & Gregory, C. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01759 · Cited by 12 · see citing works

Efferocytosis in the Tumor Microenvironment

Vaught, D., Stanford, J. C., & Cook, R. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30050-5 · Cited by 11 · see citing works

Combined Treatment of Radiotherapy and Immunotherapy for Urological Malignancies: Current Evidence and Clinical Considerations

Lei, H., Shi, M., Xu, H., Bai, S., Xiong, X., Wei, Q., & Yang, L. (2021) · Cancer Management and Research · doi:10.2147/cmar.s288337 · Cited by 11 · see citing works

Defective apoptosis of U937 cells induced by benzyl isothiocyanate (BITC)

Stasiłojć, G., Nagel, A. C., Koszałka, P., & Bigda, J. (2019) · Acta Biochimica Polonica · doi:10.18388/abp.2019_2769 · Cited by 9 · see citing works

Carcinogenesis-relevant biological events in the pathophysiology of the efferocytosis phenomenon

Sarode, G. S., Sarode, S. C., Maniyar, N., Sharma, N. K., & Patil, S. (2017) · Oncology Reviews · doi:10.4081/oncol.2017.343 · Cited by 8 · see citing works

Clearance of dying cells accelerates malignancy

Vaught, D., & Cook, R. S. (2015) · Oncotarget · doi:10.18632/oncotarget.5670 · Cited by 5 · see citing works

Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy

Zheng, Y., Han, Y., Sun, Q., & Li, Z. (2022) · Exploration · doi:10.1002/exp.20210166 · Cited by 151 · see citing works

Efferocytosis and Its Role in Inflammatory Disorders

Ge, Y., Huang, M., & Yao, Y.-M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.839248 · Cited by 143 · see citing works

MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression

Lin, J., Xu, A., Jin, J., Zhang, M., Lou, J., Qian, C., Zhu, J., Wang, Y., Yang, Z., Li, X., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2021.2024941 · Cited by 124 · see citing works

Thymosin α-1 Reverses M2 Polarization of Tumor-Associated Macrophages during Efferocytosis

Wei, Y.-T., Wang, X.-R., Yan, C., Huang, F., Zhang, Y., Liu, X., Wen, Z.-F., Sun, X.-T., Zhang, Y., Chen, Y.-Q., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4260 · Cited by 80 · see citing works

Macrophage efferocytosis in health and disease

Razi, S., Khojini, J. Y., Kargarijam, F., Panahi, S., Tahershamsi, Z., Tajbakhsh, A., & Hayat, S. M. G. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3780 · Cited by 80 · see citing works

Advances in Engineered Macrophages: A New Frontier in Cancer Immunotherapy

Yang, S., Wang, Y., Jia, J., Fang, Y., Yang, Y., Yuan, W., & Hu, J. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06616-7 · Cited by 60 · see citing works

Efferocytosis: An accomplice of cancer immune escape

Qiu, H., Shao, Z., Wen, X., Liu, Z., Chen, Z., Qu, D., Ding, X., & Zhang, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115540 · Cited by 55 · see citing works

Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target

Hu, B., Liu, G., Zhao, K., & Zhang, G. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1388999 · Cited by 38 · see citing works

Interaction, immune infiltration characteristics and prognostic modeling of efferocytosis-related subtypes in glioblastoma

Zhao, S., Wang, Q., Liu, Y., Zhang, P., Ji, W., Xie, J., & Cheng, C. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01688-4 · Cited by 30 · see citing works

MicroRNA biosensors for detection of gastrointestinal cancer

Dorosti, N., Khatami, S. H., Karami, N., Taheri‐Anganeh, M., Mahhengam, N., Rajabvand, N., Asadi, P., Movahedpour, A., & Ghasemi, H. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117245 · Cited by 25 · see citing works

Colorectal cancer-derived extracellular vesicles containing HSP70 enhance macrophage phagocytosis by up-regulating MARCO expression

Sun, Y. L., Xiao, W., Yu, Y., Jiang, Y., Xiao, Z., Huang, D., Zhong, T., Li, J., Xiang, X., He, Y., et al. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113565 · Cited by 25 · see citing works

Efferocytosis in dendritic cells: an overlooked immunoregulatory process

Ma, Y., Jiang, T., Zhu, X., Xu, Y., Wan, K., Zhang, T., & Xie, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1415573 · Cited by 24 · see citing works

Unveiling efferocytosis-related signatures through the integration of single-cell analysis and machine learning: a predictive framework for prognosis and immunotherapy response in hepatocellular carcinoma

Liu, T., Li, C. R., Zhang, J., Hu, H., & Li, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1237350 · Cited by 20 · see citing works

The Effect of Cigarette Smoke Exposure on Efferocytosis in Chronic Obstructive Pulmonary Disease; Molecular Mechanisms and Treatment Opportunities

Tajbakhsh, A., Hayat, S. M. G., Mortazavi, D., Medhati, P., Rostami, B., Savardashtaki, A., & Momtazi‐Borojeni, A. A. (2021) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2021.1978419 · Cited by 20 · see citing works

Efferocytosis: The Janus‐Faced Gatekeeper of Aging and Tumor Fate

Liu, Z., Li, Y., Ren, Y., Chen, J., Weng, S., Zhou, Z., Luo, P., Cheng, Q., Xu, H., Ba, Y., et al. (2025) · Aging Cell · doi:10.1111/acel.14467 · Cited by 19 · see citing works

The regulation of efferocytosis signaling pathways and adipose tissue homeostasis in physiological conditions and obesity: Current understanding and treatment options

Tajbakhsh, A., Hayat, S. M. G., Karami, N., Savardashtaki, A., Butler, A. E., Rizzo, M., & Sahebkar, A. (2022) · Obesity Reviews · doi:10.1111/obr.13487 · Cited by 18 · see citing works

In situ hydrogel enhances non-efferocytic phagocytosis for post-surgical tumor treatment

Lyu, J., Liu, H., Chen, L., Liu, C., Tao, J., Yao, Y., Li, L., Huang, Y., & Zhou, Z. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.041 · Cited by 16 · see citing works

Thymosin α-1 in cancer therapy: Immunoregulation and potential applications

Wei, Y., Zhang, Y., Li, P., Yan, C., & Wang, L. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109744 · Cited by 14 · see citing works

Combining bulk and scRNA‐seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDAC

Zhu, S., Cheng, Q., Zou, M., Li, C., Tang, Y., Xia, L., Jiang, Y., Gong, Z., Tang, Z., Tang, Y., et al. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18266 · Cited by 13 · see citing works

The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis

Zhu, Q., Yuan, C., Wang, D., Tu, B., Chen, W., Dong, X., Wu, K., Tao, L., Ding, Y., Xiao, W., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.06.005 · Cited by 13 · see citing works

Macrophage efferocytosis mediated by the TP63-RAC2 pathway promotes immunosuppressive remodeling in esophageal cancer

Xi, Y., Zhao, Z., Zhou, Y., Yin, C., Li, Y., Xu, X., Jin, W., Lin, C., Zhao, K., Kuang, J., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102529 · Cited by 12 · see citing works

Identification of efferocytosis-related subtypes in gliomas and elucidating their characteristics and clinical significance

Gao, M., Huang, J., Yang, B., Liu, Q., Luo, M., Yang, B., Li, X., & Liu, X. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1295891 · Cited by 12 · see citing works

Efferocytosis: a double-edged sword in microbial immunity

Mohammad‐Rafiei, F., Moadab, F., Mahmoudi, A. A., Navashenaq, J. G., & Hayat, S. M. G. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03704-8 · Cited by 10 · see citing works

Construction and evaluation of endometriosis diagnostic prediction model and immune infiltration based on efferocytosis-related genes

Pei, F., Jia, J., Lin, S., Chen, X., Wu, L., Lin, Z.-X., Sun, B., & Zeng, C. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1298457 · Cited by 10 · see citing works

Modulating macrophage-mediated programmed cell removal: An attractive strategy for cancer therapy

Li, Z., Han, B., Qi, M., Li, Y., Duan, Y., & Yao, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189172 · Cited by 9 · see citing works

Understanding the regulation of “Don’t Eat-Me” signals by inflammatory signaling pathways in the tumor microenvironment for more effective therapy

Karizak, A. Z., Salmasi, Z., Hayat, S. M. G., Asadi, M., Ghasemi, Y., Tajbakhsh, A., & Savardashtaki, A. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04452-w · Cited by 9 · see citing works

Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells

Bendre, S. V., Wang, Y., Hajyousif, B., K C, R., Bhogale, S. G., Pradeep, D., Krawczynska, N., Schane, C. P., Weisser, E., Singh, A., et al. (2026) · Science Advances · doi:10.1126/sciadv.adx5490 · Cited by 8 · see citing works

Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma

Xu, K., Liu, Y. S., Luo, H., & Wang, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1218244 · Cited by 8 · see citing works

Identification and analysis of key genes related to efferocytosis in colorectal cancer

Zhang, S., Jiang, Y. H., Shi, L., Wei, T., Lai, Z., Feng, X., Li, S., & Tang, D. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-01967-8 · Cited by 7 · see citing works

Glycopolymeric Nanoparticles Block Breast Cancer Growth by Inhibiting Efferocytosis in the Tumor Microenvironment

Shofolawe-Bakare, O. T., Toragall, V. B., Hulugalla, K., Mayatt, R., Iammarino, P., Bentley, J. P., Smith, A. E., & Werfel, T. A. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c06534 · Cited by 7 · see citing works

Efferocytosis and inflammation: a bibliometric and systematic analysis

Cao, X., Li, F., Xie, X. S., Ling, G., Tang, X., He, W., Tian, J., & Ge, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1498503 · Cited by 7 · see citing works

A novel efferocytosis-related gene signature for predicting prognosis and therapeutic response in bladder cancer

Yu, W., Yao, D., Ma, X., Hou, J., & Tian, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-04037-w · Cited by 6 · see citing works

Plant‐Derived Phytochemicals and Their Nanoformulations for Inducing Programed Cell Death in Cancer

Wang, H., Wang, X., Wang, L., Wang, H., & Zhang, Y. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400197 · Cited by 5 · see citing works

Molecular Mechanisms and Therapeutic Potential of Resolvins in Cancer - Current Status and Perspectives

Tajbakhsh, A., Yousefi, F., Farahani, N., Savardashtaki, A., Reiner, Ž., Jamialahmadi, T., & Sahebkar, A. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230727100123 · Cited by 5 · see citing works

Macrophage polarization in tumors: The impact of efferocytosis.

Zhang, Y., Zang, H., & Wen, Q.-Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115807 · Cited by 5 · see citing works

Modulation of efferocytosis and inflammation resolution by live and non-live probiotics through gut microbiota interactions in preclinical and clinical studies

Arianejad, M., Tajeddini, F., Zareardalan, M., Hosseinpour-Soleimani, F., Sisakht, M., Tajbakhsh, A., Pirsalehi, M.-T., & Negahdaripour, M. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105498 · Cited by 4 · see citing works

Development of a prognostic model for glioblastoma multiforme based on the expression levels of efferocytosis-related genes

Xu, W., Han, L., Zhu, P., Cheng, Y., & Chen, X. (2023) · Aging · doi:10.18632/aging.205422 · Cited by 4 · see citing works

Efferocytosis-related gene IL33 predicts prognosis and immune response and mediates proliferation and migration in vitro and in vivo of breast cancer

Xiao, H., Cheng, X., Zhang, Z., Chen, L., Xie, C., & Tang, M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1533571 · Cited by 3 · see citing works

Efferocytosis and infertility: Implications for diagnosis and therapy

Bavarsad, S. B., Shahryarhesami, S., Karami, N., Naseri, N., Tajbakhsh, A., & Hayat, S. M. G. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104413 · Cited by 2 · see citing works

Efferocytosis-associated transcriptomic patterns characterize prognosis and immune landscape in osteosarcoma

Song, X., Tou, X., Li, L., Wang, F., Chengqun, Q., Wang, R., & Shen, J. (2026) · Journal of bone oncology · doi:10.1016/j.jbo.2026.100743 · Cited by 2 · see citing works

Establishment of a novel efferocytosis potential index predicts prognosis and immunotherapy response in cancers

Chen, P., Li, Z., & Li, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30337 · Cited by 2 · see citing works

Therapeutic implication of targeting mitochondrial drugs designed for efferocytosis dysfunction

Liu, W.-T., Li, C.-Q., Fu, A.-N., Yang, H., Xie, Y., Yao, H., & Yi, G. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2386620 · Cited by 2 · see citing works

Development and validation of a prognostic model for efferocytosis-associated genes in cervical squamous cell carcinoma

Ma, L., Zhao, L., Zhang, Y., Ma, Y., Shang, Q., & Liu, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-02901-9 · Cited by 2 · see citing works

Identification of C1QA as a prognostic marker and regulator of immunosuppressive neutrophils in early-stage lung adenocarcinoma through integrated bioinformatics analyses

Nguyen, Q. A., Wang, H., Verghese, E., Iscaro, J., Steinfort, D., McQualter, J. L., & Bozinovski, S. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01881-y · Cited by 1 · see citing works

Enhancing Chemosensitivity With Quercetin: Mechanistic Insights Into MerTK and Associated Signaling Pathways

Jafari, S., & Ghasemi, S. (2025) · Cancer Reports · doi:10.1002/cnr2.70370 · Cited by 1 · see citing works

Efferocytosis: Signaling Pathways and New Therapeutic Strategies for Diseases

Wang, L., Ge, J., Wang, Z., Fang, Y., Jia, Y., Zhang, R., & Qin, Y. (2026) · MedComm · doi:10.1002/mco2.70764 · Cited by 1 · see citing works

A Liposomal Nanovaccine Reprograms Post-Ablation Macrophages to Sustain Antitumor Immunity in Hepatocellular Carcinoma

Qiu, F., Hu, H., Li, K., Qi, H., Liu, P., Zou, T., Gong, P., Weng, Q., Shen, L., Zheng, L., et al. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.07.023 · Cited by 1 · see citing works

Research Progress of Nano-Drugs Remodeling TAMs for Enhancing Cancer Immunotherapy

刘, 湘. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451389 · Cited by 1 · see citing works

Integration of Machine Learning Algorithms and Single‐Cell Sequencing Analysis Reveals the Efferocytosis‐Related Molecular Subtype and Prognostic Scoring Index in Colon Adenocarcinoma

Ju, K., Liu, X., Wang, Q., Liu, X., Li, D., & Tan, B. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16985 · Cited by 1 · see citing works

Prognostic biomarker RIMS1 and its association with immune infiltration in glioblastoma

Tao, E., Song, Q., Tang, J., Xin, W., Xiao, Z., Liu, Z., & Xie, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-99499-3

A Novel 14-Gene Panel Associated With Efferocytosis for Predicting Pancreatic Cancer Prognosis Through Bulk and Single-Cell Databases

Wu, Y., Zhao, L., Yi, D., Tian, Z., Dong, B., Ye, C., Liu, J., Ma, H., & Zhao, W. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl40818

Inhibition of AXL dependent non-professional efferocytosis sensitizes pancreatic cancer to immune checkpoint blockadePreprint

Park, J. Y., McCaw, T. R., Dao, H., Donahue, T. R., Crompton, J., Vlashi, E., & Girgis, M. D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.12.669943

Development of a prognostic RiskScore model using efferocytosis-related signature genes for lung adenocarcinoma

Dai, Z., Jin, S., Huang, S., Liu, B., Shen, X., & Jin, Y. (2025) · PeerJ · doi:10.7717/peerj.19892

Identification of Seven in absentia homolog 2 as a potential efferocytosis-related biomarker in diabetic foot ulcers

Zhao, J., Liu, X., Sun, Q., He, Y., Wang, J., Liu, J., Li, C., Yan, F., Jin, H., Xue, Z., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0334163

Additional file 1 of Interaction, immune infiltration characteristics and prognostic modeling of efferocytosis-related subtypes in glioblastoma

Zhao, S., Wang, Q., Liu, Y., Zhang, P., Ji, W., Xie, J., & Cheng, C. (2024) · Figshare · doi:10.6084/m9.figshare.26628304

Subtype identification and risk model establishment to predict prognosis and drug therapy response in colon cancer based on efferocytosis-related genes

Sun, X., & Chen, F. (2026) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2026.2645174

Construction of an efferocytosis related signature to predict the prognosis of pancreatic ductal adenocarcinoma

Li, J., Du, Z., Liu, X., Pan, T., Zheng, Y., & He, Y. (2026) · Discover Oncology · doi:10.1007/s12672-026-05088-9

Taraxerol targets the HIF1A-NEK6 axis to block TDE-mediated M2 macrophage polarization and inhibits NSCLC progression

Yang, Q., Li, H., Guo, B., & Gao, R. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156603

Drugging the efferocytosis process for treating hepatic fibrosis: dual roles, mechanisms, and therapeutics

Chen, Y., Sun, Y., Chen, X., Liu, Y., & Wang, H. (2026) · Targetome · doi:10.48130/targetome-0026-0031

Modulating macrophage efferocytosis: Drug delivery strategies for enhancement, mimicry, and inhibition

Liu, Z., Wu, J., Lyu, J., Zhou, Z., & Huang, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.07.051

Thymosin α-1 in cancer therapy: Immunomodulatory mechanisms, clinical applications, and translational perspectives

Chuang, S.-C., Hung, P.-C., Rethi, L., Lin, Y., Chau, H. D., Pham, V. K., Vo, A. T., Nguyen, H. T., Tzou, K.-Y., & Chuang, A. E.-Y. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179277

Spatial and Temporal Heterogeneity of Macrophage Efferocytosis in Tumors: Emerging Implications for Immunotherapy Biomarkers and Therapeutic Timing

Li, S., Li, J., Zhang, Z., Wang, S., & Ma, C. (2026) · Cancer Medicine · doi:10.1002/cam4.72195

The Efferocytosis‐Driven Macrophage Polarization: A Concerto in the Tumor Immunosuppressive Microenvironment

Chen, Q., Wu, C., Huang, C., & Zhou, H. (2026) · MedComm · doi:10.1002/mco2.71038

Converting ferroptosis into an in situ vaccine via an efferocytosis-blocking nanoreactor to reignite cancer-immunity cycle

Qu, X., Qi, J., Liu, Y., Zhang, J., Yang, S., Yuan, B., Zhang, C., Wang, H., & Dong, Z. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.183364

Regulation of efferocytosis as a novel cancer therapy

Zhou, Y., Yao, Y., Deng, Y., & Shao, A. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00542-9 · Cited by 100 · see citing works

Efferocytosis: An accomplice of cancer immune escape

Qiu, H., Shao, Z., Wen, X., Liu, Z., Chen, Z., Qu, D., Ding, X., & Zhang, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115540 · Cited by 55 · see citing works

Macrophage polarization in tumors: The impact of efferocytosis.

Zhang, Y., Zang, H., & Wen, Q.-Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115807 · Cited by 5 · see citing works

Efferocytosis and the Story of “Find Me,” “Eat Me,” and “Don’t Eat Me” Signaling in the Tumor Microenvironment

Banerjee, H. N., Bartlett, V., Krauss, C., Aurelius, C., Johnston, K., Hedley, J., & Verma, M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_8 · Cited by 17 · see citing works

Efferocytosis Creates a Tumor Microenvironment Supportive of Tumor Survival and Metastasis

(2015) · Cancer Cell &amp; Microenvironment · doi:10.14800/ccm.666 · Cited by 44 · see citing works